CDC25B over-expression was found to be significantly associated with a high proliferative activity of human non-hodgkin's lymphomas [18], and to enhance the proliferation of mammary epithelial cells in transgenic mice over-expressing human CDC25B [34]. The gene discussed is CDC25B; the disease is non-Hodgkin lymphoma.